PUMA BIOTECHNOLOGY, INC. Cash
PUMA BIOTECHNOLOGY, INC. (PBYI) had Cash of $13.90 million as of 2017-12-31, per its 10-K filed 2019-03-01.
Discontinued › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Cash and Cash Equivalent
us-gaap:Cash · last filed 2019-03-01
- 2017-12-31: Cash $13.90M.
- 2011-09-30: Cash $25.47K.
- 2011-06-30: Cash $1.75K.
- 2010-12-31: Cash $462.00.
| Period end | Cash |
|---|---|
| 2017-12-31 | $13.90M 10-K · filed 2019-03-01 |
| 2011-09-30 | $25.47K 10-Q · filed 2011-11-14 |
| 2011-06-30 | $1.75K 10-Q · filed 2011-08-15 |
| 2010-12-31 | $462.00 10-Q · filed 2011-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |